ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

Proton Beam Radiation Helps Cancer Patients Retain Vision

August 26, 2005